Roivant Sciences Ltd. (ROIV)
41.43
+6.50
(+18.61%)
USD |
NASDAQ |
Sep 08, 15:59
41.30
-0.13
(-0.31%)
After-Hours: 20:00
Roivant Sciences Total Liabilities (Quarterly) : 384.62M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 384.62M |
| March 31, 2026 | 435.63M |
| December 31, 2025 | 251.14M |
| September 30, 2025 | 257.14M |
| June 30, 2025 | 216.70M |
| March 31, 2025 | 249.74M |
| December 31, 2024 | 256.38M |
| September 30, 2024 | 625.99M |
| June 30, 2024 | 601.16M |
| March 31, 2024 | 773.95M |
| December 31, 2023 | 728.10M |
| September 30, 2023 | 739.91M |
| June 30, 2023 | 802.51M |
| Date | Value |
|---|---|
| March 31, 2023 | 782.02M |
| December 31, 2022 | 775.82M |
| September 30, 2022 | 701.38M |
| June 30, 2022 | 822.52M |
| March 31, 2022 | 523.70M |
| December 31, 2021 | 529.62M |
| September 30, 2021 | 652.01M |
| June 30, 2021 | 474.86M |
| March 31, 2021 | 527.69M |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | 368.36M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Oxford Biomedica Plc | -- |
| Bicycle Therapeutics Plc | 96.32M |
| Arbutus Biopharma Corp. | 15.29M |
| Moderna, Inc. | 4.20B |
| Adaptimmune Therapeutics Plc | 201.59M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.306B |
| Shareholders Equity (Quarterly) | 4.231B |
| Debt to Equity Ratio | 0.0253 |
| Current Ratio | 16.72 |
| Net Debt Paydown Yield | -0.01% |